US Patent Issued to Ripple Therapeutics on Dec. 30 for "Compositions and methods for the treatment of pain and dependence disorders" (Canadian Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,469, issued on Dec. 30, was assigned to Ripple Therapeutics Corp. (Toronto).

"Compositions and methods for the treatment of pain and dependence disorders" was invented by Ian Charles Parrag (Toronto), Wendy Alison Naimark (Toronto), Matthew Alexander John Statham (Milton, Canada), Georgios Rizis (Toronto) and Kyle Giovanni Battiston (Toronto).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are (e.g., controlled release) compositions for the treatment of acute or chronic diseases or disorders. Described herein are processable opioid conjugates. Also described herein are compositions and methods for the treatment of central nervous syste...